Stimulants (Adderall, Vyvanse, Ritalin) are the most effective ADHD treatments and work by boosting dopamine and norepinephrine. Non-stimulants like atomoxetine and guanfacine are real alternatives, especially when stimulants cause side effects or substance use is a concern. Stimulants are Schedule II controlled substances, meaning prescribing rules are strict.
Medications for ADHD: A Plain-English Guide
Attention-deficit/hyperactivity disorder (ADHD) is one of the most extensively studied psychiatric conditions, and its medications have among the strongest evidence bases in all of psychiatry. Still, newly diagnosed patients — adults and parents of children alike — often find the landscape confusing. Why do stimulants calm people down instead of revving them up? What is the difference between Adderall and Vyvanse? When would a doctor choose a non-stimulant? This guide answers those questions.
ADHD medications fall into two broad categories: stimulants, which are first-line and most effective, and non-stimulants, which offer meaningful alternatives when stimulants are not a good fit. Both categories work by improving communication in the brain's prefrontal cortex — the region responsible for attention, planning, and impulse control.
Stimulant Medications
Adderall contains a mixture of amphetamine salts that work by causing neurons to release dopamine and norepinephrine while also blocking their reabsorption. This increases the availability of both neurotransmitters in the synaptic gap, strengthening signals in the prefrontal cortex that regulate attention and impulse control. Adderall IR (immediate-release) lasts approximately 4–6 hours; Adderall XR (extended-release) lasts 8–12 hours. It is FDA-approved for ADHD in children aged 3 and older and in adults.
Lisdexamfetamine is a prodrug — it is inactive until the body converts it into dextroamphetamine. This conversion happens gradually in the bloodstream, producing a smoother onset and a longer, more consistent effect (up to 14 hours) compared to standard amphetamines. The prodrug design also reduces the potential for misuse, since crushing or snorting the pill does not produce a faster high. Vyvanse is FDA-approved for ADHD in children 6 and older and in adults, and also for binge eating disorder in adults.
Methylphenidate works differently from amphetamines: instead of causing extra neurotransmitter release, it primarily blocks the reabsorption (reuptake) of dopamine and norepinephrine. The net effect is similar — more dopamine available in synapses — but the mechanism differs. This distinction matters clinically because some patients respond better to one class than the other, and side effect profiles differ slightly. Ritalin IR lasts 3–5 hours; Concerta uses a special delivery system to last about 12 hours.
Non-Stimulant Medications
Atomoxetine is an SNRI-like drug specifically approved for ADHD — it selectively blocks norepinephrine reuptake in the prefrontal cortex. Unlike stimulants, it is not a controlled substance, which means it can be refilled without monthly prescriptions and can be prescribed more freely. It takes 4–6 weeks to reach full effect, making it more similar to antidepressants in its time course. Atomoxetine is FDA-approved for children, adolescents, and adults, making it one of the few options with that full age range approval.
Guanfacine is an alpha-2A adrenergic receptor agonist originally developed as a blood pressure medication. It works in the prefrontal cortex by strengthening synaptic connections that regulate attention and impulse control — a distinct mechanism from stimulants. Intuniv (extended-release guanfacine) is FDA-approved for ADHD in children and adolescents aged 6–17. It is particularly useful when stimulants cause intolerable side effects, when a child has a tic disorder, or as an add-on to stimulant therapy. It can cause sedation and blood pressure changes.
Clonidine, like guanfacine, is an alpha-2 agonist repurposed for ADHD. Kapvay is FDA-approved for ADHD in children and adolescents aged 6–17. It is more sedating than guanfacine and may be used when sleep is a concern or when hyperactivity and impulsivity are prominent. Clonidine should not be stopped suddenly because it can cause rebound high blood pressure. It is often used as an adjunct to stimulants rather than a standalone treatment.
Schedule II: What It Means for Patients
Stimulant ADHD medications — all amphetamines and methylphenidate — are classified as Schedule II controlled substances by the DEA. This is the most restrictive category for drugs with accepted medical use. In practical terms, it means: prescriptions cannot be refilled (a new prescription is required each month), in most states prescriptions must be written and signed on tamper-resistant paper or sent electronically through a certified system, prescribers may have limits on how far in advance they can date a prescription, and carrying another person's ADHD medication is a federal offense.
These rules exist because amphetamines and methylphenidate have genuine potential for misuse and diversion, particularly in academic settings. For patients with a legitimate diagnosis, navigating the system is an inconvenience but manageable. Non-stimulants like atomoxetine, guanfacine, and clonidine are not scheduled, offering more flexibility in prescribing.
Adults vs. Children: Key Differences
The brain mechanisms of ADHD are the same across ages, but presentation, drug metabolism, and treatment context differ. Children often show more visible hyperactivity; adults more commonly present with inattention, disorganization, and difficulty completing tasks. Adults also metabolize medications differently and are more likely to have comorbid depression, anxiety, or substance use disorders that influence medication choice. Stimulants work well across all ages. Guanfacine and clonidine have pediatric-specific FDA approvals. Atomoxetine is approved across the full age range. Some adults find non-stimulants sufficient; others require stimulants for adequate effect.
Stimulant medications can raise heart rate and blood pressure and are generally not recommended for people with certain heart conditions. Always inform your prescriber of any cardiovascular history before starting ADHD treatment.
Frequently Asked Questions
Why are ADHD stimulants classified as Schedule II?
Schedule II means the DEA has determined these drugs have a high potential for abuse that may lead to severe psychological or physical dependence. Amphetamines and methylphenidate share this classification with opioids like oxycodone. This restricts how they can be prescribed — no refills, monthly new prescriptions required, and strict record-keeping by pharmacies.
Do ADHD medications work differently in adults than in children?
The core pharmacology is the same, but adult ADHD often presents differently — less hyperactivity, more inattention and executive dysfunction. Adults may also have more complex comorbidities. Non-stimulants like atomoxetine are FDA-approved for adults; guanfacine and clonidine are primarily studied and approved in children and adolescents.
What happens if someone without ADHD takes a stimulant?
People without ADHD still experience stimulant effects — increased alertness, reduced appetite, elevated heart rate — but also tend to experience more pronounced euphoria, which drives misuse potential. In people with ADHD, stimulants produce a calming, focusing effect because they correct a deficit in dopamine signaling. In neurotypical people, they overstimulate an already adequate system.
Need to identify a pill by its imprint, shape, or color?
Use the PillID Pill Identifier →